Expansion in Senegal & Cameroon

On the Global Anti-Counterfeiting Day, Meditect and UPSA announce the expansion of their partnership to other UPSA medicines, but also to 2 other countries: Senegal and Cameroon.

Double interview in Mindhealth

Romain and Loïc Bernard, General Manager of UPSA Africa, detail the use case of the pilot project deployed in Côte d'Ivoire, and the prospects for deployment on a larger scale.

Interview - Romain Renard @ Sciences Po

In this interview organized by Sciences Po, Romain presents Meditect's goal and ambitions.

TICpharma article on blockchain in the pharmaceutical industry

This article looks back at the lack of concrete use cases for blockchain in the pharmaceutical industry, and includes Meditect among the initiatives that are working and have strong growth potential.

Column - Arnaud Pourredon in « Les Echos »

In this personal column, Arnaud looks back on the genesis of Meditect and its evolution. He also presents the company’s commitment to the fight against counterfeit drugs in the coming years.

Interview - Romain Renard in « Good morning business »

Following his victory in the BFM Academy final, Romain is interviewed by Christophe Jakubyszyn and Sandra Gandoin to talk about the stakes involved in counterfeit drug trafficking, and Meditect's ambitions for the future.

Meditect wins the 15th edition of the BFM Academy

They were only four out of the 800 young companies originally engaged in the BFM Business competition. During the final held live on October 12, Meditect won the award, with more than 40% of the online votes. It’s a first in the history of the competition.

Interview - Arnaud Pourredon in « Check up Santé »

Arnaud was invited by Fabien Guez on the « Check up Santé » programme to raise awareness about the trafficking of falsified medicines in sub-Saharan. He also presents the more than convincing results of Meditect in Côte d’Ivoire, and the ambition to become a key player in the access to safe medicines for patients in the region.

Meditect wins Huawei’s Digital InPulse competition

Focusing this year on projects with positive impact on society, the annual Digital InPulse competition organised by Huawei, the Richelieu Committee, Business France and the French Tech network, rewarded Meditect for its commitment to the fight against falsified medicines.

Column - Arnaud Pourredon in « Le Parisien »

Arnaud, who has been living in Abidjan for more than a year, testifies about the situation in Africa with regard to COVID-19, and presents Meditect’s commitment in the fight against fake medicines.

Interview - Romain Renard on B Smart

Interviewed by Eva Ben-Saadi and Emilie Kovacs in the program « Smart Impact », Romain present Meditect and talks about the immense challenge of counterfeit medicine trafficking. He explains how the whole Meditect team works every day to fight this public health scourge.

Meditect raises its first institutional round with LBO France

After a first round in 2019 with business angels, BPI Nouvelle-Aquitaine and the Nouvelle-Aquitaine Region, the Bordeaux-based startup is closing its first institutional fund-raising with LBO France through its Digital Health 2 fund.

Meditect, partner of the Congress of the National Union of Pharmacists, Abidjan

« Meditect is particularly interested in the last link of the distribution chain: the pharmacist and the patient. No technology can be deployed effectively without a continuous and reinforced presence on the field. Meditect opened its subsidiary in Abidjan in August 2019 and continues to recruit employees to be in contact with pharmacists and patients. ». Meditect is proud to sponsor the 1st Congress of the National Union of Private Pharmacists of Ivory Coast. Over 400 pharmacy owners gathered at the Heden Golf Hotel to discover the latest pharma innovations, discuss developments in the private sector and the issue of street medicines.

BPI Deeptech Tour, Bordeaux

Romain Renard is invited to present the blockchain technology developed by Meditect during the BPI Deeptech Tour in Bordeaux. It is from a need in the field that we have identified blockchain as the optimal solution to tackle the safety issues related to the distribution of medicines that need to be addressed.

Meditect receives support from the Nouvelle-Aquitaine region and Bpifrance to accelerate its research

Having received support from the ecosystem of the Nouvelle-Aquitaine region (grant Digital Prototyping, support from the Unitec accelerator) since 2017, Meditect is diversifying its funds through aid from the region and Bpifrance Nouvelle-Aquitaine to accelerate its research.

TEDx, Abidjan

TEDx, Abidjan

« Blockchain is a virtuous technology: it ensures robustness, immutability and transparency, three essential criteria for securing a supply chain. » Arnaud Pourredon is one of the speakers at TEDx Abidjan. He presents the blockchain technology used by Meditect to secure and optimize the medicine supply chain.

World Customs Organization, Brussels

“Labelling, serialization, authentication: what solutions are available and how can Customs benefit from them?” For the 16th consecutive year, the WCO held its counterfeiting conference (Counterfeiting and Piracy Group). Romain Renard presents the innovative solution developed by Meditect, which enables unit-level medicines’ identification and a better monitoring of their distribution.

Stakes and challenges of the pharmaceutical market in Africa, LEEM, Paris

Meditect is invited to present its solution for securing and optimizing medicine distribution.

EIT Health

EIT Health

EIT Health is one of the “Knowledge and Innovation Communities”, or KICs, around the theme of health, launched and funded by the European Institute of Innovation and Technology (EIT) in 2015. Each year, the most innovative start-ups are chosen after a selective process to join the EIT network and benefit from the expertise of more than 140 academic and industrial partners across Europe. Meditect is one of the selected French start-ups and thus joined the EIT network.

Meditect and UPSA join forces to fight falsified medicines

The Meditect start-up, specialized in medicine traceability, announces the signing of an agreement with UPSA, marking the first time its solution has been launched on the market. As part of the implementation of a pilot project in Ivory Coast, Meditect will improve the traceability of UPSA medicines. The start-up will thus enable patients and pharmacists to check the authenticity of these medicines thanks to free applications, accessible via smartphone. The deployment of Meditect is initially planned for one of the most widely used medicines in West Africa.

Pharmaceutical Anti-Counterfeiting, Zurich

Meditect participates in the first international trade show dedicated to the fight against medicine counterfeiting. Held in Zurich, this forum brings together hundreds of specialists of the fight against counterfeiting from various fields (industrial, academic, institutional). Meditect is presented by Romain Renard in a plenary session.

Meditect wins the 'Blockchain Innovation Challenge'

Despite very strong competition, the social impact of the project was convincing, and the first prize was awarded to Meditect to support its development. The entire team is very proud of this recognition, especially Romain Renard, co-founder of Meditect and Sciences Po alumni.

Romain Renard et Arnaud Pourredon present Meditect at the “Alliance Programme” in New York

Created in 2002, the “Alliance Programme” is an academic partnership between Columbia University and three prestigious French institutions: University Paris I Panthéon-Sorbonne, École Polytechnique and Sciences Po Paris. Its objective is to foster exchanges between these four institutions through numerous initiatives, including the “Blockchain Innovation Challenge”. Meditect had the privilege of representing Sciences Po at the final of the 1st edition of this competition and answered questions from journalists in New York City.

Meditect at PharmagoraPlus 2019

PharmagoraPlus, European pharmacy trade show, welcomes nearly 14,000 healthcare professionals and 400 companies to discuss the new challenges in the field. Meditect proudly presents its solution to fight falsified medicine trafficking.

Arnaud Pourredon is on Forbes’ « 30 under 30 » list for 2019

Every year, Forbes magazine publishes a ranking of the thirty most influential European personalities under the age of thirty in the fields of finance, media, technology and health. Arnaud Pourredon is listed in the “Science and Healthcare” category and is honored to represent Meditect in its fight against the falsified medicine scourge.

Presentation of Meditect by the Spanish media « The Daily Prosper »

In October 2018, following its active participation in various trade shows, Meditect caught the attention of Spanish media « The Daily Prosper », that produced a video presenting Meditect (in Spanish). The video report portrays the daily life in Côte d’Ivoire and introduces Arnaud Pourredon, co-founder of Meditect, discussing the current problem of falsified medicines in West Africa and explaining how Meditect’s solution aims to fight this scourge and improve public health thanks to blockchain technology.

Meditect utilise des cookies pour assurer le fonctionnement de ses services.

En savoir plus